Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $69.9 million.

  • Surgery Partners' Accumulated Expenses rose 770.42% to $69.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.9 million, marking a year-over-year increase of 770.42%. This contributed to the annual value of $60.4 million for FY2024, which is 1815.72% down from last year.
  • Latest data reveals that Surgery Partners reported Accumulated Expenses of $69.9 million as of Q3 2025, which was up 770.42% from $59.3 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Accumulated Expenses peaked at $83.8 million during Q1 2022, and registered a low of $59.3 million during Q2 2025.
  • For the 5-year period, Surgery Partners' Accumulated Expenses averaged around $70.5 million, with its median value being $68.9 million (2022).
  • Per our database at Business Quant, Surgery Partners' Accumulated Expenses surged by 6295.4% in 2021 and then plummeted by 2326.97% in 2023.
  • Surgery Partners' Accumulated Expenses (Quarter) stood at $77.1 million in 2021, then decreased by 10.64% to $68.9 million in 2022, then grew by 7.11% to $73.8 million in 2023, then dropped by 18.16% to $60.4 million in 2024, then grew by 15.73% to $69.9 million in 2025.
  • Its last three reported values are $69.9 million in Q3 2025, $59.3 million for Q2 2025, and $67.0 million during Q1 2025.